- Home
- ATHA vs LIQT Comparison
ATHA vs LIQT Comparison
Compare ATHA & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- LIQT
- Stock Information
- Founded
- ATHA 2011
- LIQT 2004
- Country
- ATHA United States
- LIQT Denmark
- Employees
- ATHA N/A
- LIQT N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- LIQT Industrial Machinery/Components
- Sector
- ATHA Health Care
- LIQT Technology
- Exchange
- ATHA Nasdaq
- LIQT Nasdaq
- Market Cap
- ATHA 21.0M
- LIQT 16.9M
- IPO Year
- ATHA 2020
- LIQT N/A
- Fundamental
- Price
- ATHA $0.43
- LIQT $1.61
- Analyst Decision
- ATHA Buy
- LIQT Strong Buy
- Analyst Count
- ATHA 4
- LIQT 2
- Target Price
- ATHA $11.25
- LIQT $4.60
- AVG Volume (30 Days)
- ATHA 210.5K
- LIQT 4.1K
- Earning Date
- ATHA 03-04-2025
- LIQT 03-20-2025
- Dividend Yield
- ATHA N/A
- LIQT N/A
- EPS Growth
- ATHA N/A
- LIQT N/A
- EPS
- ATHA N/A
- LIQT N/A
- Revenue
- ATHA N/A
- LIQT $15,128,295.00
- Revenue This Year
- ATHA N/A
- LIQT N/A
- Revenue Next Year
- ATHA N/A
- LIQT $31.19
- P/E Ratio
- ATHA N/A
- LIQT N/A
- Revenue Growth
- ATHA N/A
- LIQT N/A
- 52 Week Low
- ATHA $0.41
- LIQT $1.51
- 52 Week High
- ATHA $4.21
- LIQT $3.42
- Technical
- Relative Strength Index (RSI)
- ATHA 34.62
- LIQT 39.80
- Support Level
- ATHA $0.42
- LIQT $1.64
- Resistance Level
- ATHA $0.46
- LIQT $1.66
- Average True Range (ATR)
- ATHA 0.04
- LIQT 0.08
- MACD
- ATHA -0.00
- LIQT -0.01
- Stochastic Oscillator
- ATHA 10.85
- LIQT 12.12
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.